BioAtla, Inc.

BCAB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 41 employees
103
SEC Filings
$1.69
Close 2026-08-31
41
Employees

Business Summary

BioAtla, Inc. is a clinical-stage biopharmaceutical company developing conditionally active biologic (CAB) antibody-based therapeutics for solid tumor cancers. Its CAB technology exploits pH differences between tumor microenvironments and healthy tissue to selectively bind cancer cells, reducing toxicity. Lead candidates include ozuriftamab vedotin (BA3021), a CAB anti-ROR2 ADC, and BA3182, a CAB-EpCAM x CAB-CD3 bispecific antibody. As of March 2026, the company is exploring strategic options including asset sales and licensing.

Latest Stock Quote

BCAB 2026-08-31 $1.69 O:$1.76 H:$2.13 L:$1.31 Vol:0.1M VWAP:$1.7523
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134499EDGAR102K words
2025-03-282024-12-310000950170-25-046217EDGAR92K words
2024-03-262023-12-310000950170-24-036548EDGAR89K words
2023-03-232022-12-310000950170-23-009551EDGAR94K words
2022-02-282021-12-310000950170-22-002303EDGAR—
2021-03-242020-12-310001193125-21-092812EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001193125-26-349542EDGAR68K words
2025-11-132025-09-300001193125-25-280435EDGAR61K words
2025-08-072025-06-300000950170-25-105220EDGAR60K words
2025-05-062025-03-310000950170-25-064594EDGAR56K words
2024-11-072024-09-300000950170-24-123506EDGAR57K words
2024-08-082024-06-300000950170-24-094164EDGAR55K words
2024-05-142024-03-310000950170-24-059757EDGAR52K words
2023-11-072023-09-300000950170-23-060389EDGAR56K words
2023-08-012023-06-300000950170-23-036554EDGAR56K words
2023-05-112023-03-310000950170-23-021358EDGAR54K words
2022-11-042022-09-300000950170-22-022036EDGAR—
2022-08-092022-06-300000950170-22-016149EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-280001539497-26-002373EDGAR1K words
2026-07-160001193125-26-306117EDGAR1K words
2026-04-020001193125-26-140053EDGAR1K words
2026-03-310001193125-26-134501EDGAR3K words
2026-03-230001193125-26-119698EDGAR1K words
2026-03-020001539497-26-000812EDGAR3K words
2026-02-090001193125-26-041852EDGAR1K words
2026-02-060001193125-26-041367EDGAR2K words
2026-01-300001193125-26-031942EDGAR5K words
2026-01-120001193125-26-010458EDGAR2K words

103 total filings indexed. 75 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

solid-tumor-oncology antibody-drug-conjugates-(adc) t-cell-engaging-bispecific-antibodies immuno-oncology car-t-cell-therapy cab-(conditionally-active-biologics)-technology protein-activated-chemical-switches-(pacs) mmae-payload-with-cleavable-linker sugar-based-linker-(next-generation-cab-adc-platform)

Company Identity

CIK0001826892
TickerBCAB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.bioatla.com
Listed2020-12-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: a415f03eb46fe35278667f8ad2651df5cc5ae645fa71447ca9ff3e002a699105
parent: ce875b71495fb9aeac18cfe30f40133a344dc8880fd08fe0062afc009fc46448
content hash: 9b3afde0d5d74284029619076a6b67ec5bb628e18902876eaca795124b77e4c7
signed: 2026-09-29T19:00:26.274Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BCAB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BCAB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BCAB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.